Grand Challenges Canada: A Vote for Oxalys is a Vote for Affordable Dementia Treatment

Funded by the Government of Canada, Grand Challenges Canada is dedicated to supporting bold ideas with big impact in global health.


The Challenge

Massive inequalities in health exist across the globe because of persistent global health challenges. Historically, some of the greatest impacts in global health were from innovators who tried out bold ideas. The discovery of vaccines over 200 years ago and of antibiotics in the last century are classic examples of unorthodox thinking that resulted from bold ideas that have had big impact and saved millions of lives.

The Stars in Global Health program supports bold ideas with big impact from the best and brightest talent, both in Canada and in low- and lower-middle-income countries, to use scientific/technical, social and business innovation to address some of the most pressing global health problems.

The Solution proposed by Oxalys Pharmaceuticals:
Low-cost and effective therapy for neurodegenerative disease

The Essence of the Idea:

Oxalys has developed a low-cost treatment for cognitive decline associated with neurodegenerative diseases and AIDS-related dementia. It has been shown clinically to improve memory in humans, is safe, and can be manufactured in developing countries.

                       ***CLICK HERE TO VOTE***

In order to vote, please view the 2-minute project video and vote for the project titled: “Low-cost and effective therapy for neurodegenerative disease”. Just click on the thumbs up icon to indicate “I LIKE”.

A Vote for Oxalys is a Vote for Affordable Dementia Treatment

Recent Posts